Matthew Heath

Matthew Heath

Company: Allergy Therapeutics

Job title: Principal Scientist, Innovation & Product Development


Developing Proof of Concept for a Virus-Like Particle Single Allergen Approach 11:00 am

Genetic fusion design of a peanut allergen-VLP vaccine Displaying peanut allergens on VLPs reduces its reactogenicity Single allergen combined with VLPs protects against a complex peanut extract First clinical study using novel VLPs against peanut allergy now plannedRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.